Federal Register: November 26, 2003 (Volume 68, Number 228)
DOCID: FR Doc 03-29481
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
NOTICE: NOTICES
ACTION: Meetings:
SUBJECT CATEGORY:
National Institutes of Allergy and Infectious Diseases; Notice of Closed Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Vaccine Development and Immunity: Adjuvants and TLR.
Date: December 16, 2003.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: 6700B Rockledge Drive, 3134, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Nancy B. Saunders, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, Room 3134, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 208927616, (301) 4353559, ns120v@nih.gov.
(Catalogue of Federal Domestic Assistant Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: November 19, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 0329481 Filed 112503; 8:45 am]
BILLING CODE 414001M
SUMMARY:
National Institute of Allergy and Infectious Diseases,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Vaccine Development and Immunity: Adjuvants and TLR.
Date: December 16, 2003.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: 6700B Rockledge Drive, 3134, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Nancy B. Saunders, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, Room 3134, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 208927616, (301) 4353559, ns120v@nih.gov.
(Catalogue of Federal Domestic Assistant Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: November 19, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 0329481 Filed 112503; 8:45 am]
BILLING CODE 414001M